Veeva rises from 8th to 3rd
in just two years
Veeva also named a ‘Leader’ by
Nucleus and IDC and ‘Most Innovative Platform’ by PharmaVOICE
PLEASANTON, Calif.--(BUSINESS WIRE)--
Veeva Systems is among the top
three most preferred life sciences software vendors, according to
IDC Health Insights’ Leading Indicators in Life Sciences IT Spending
Surveyi, which measures planned investments for 2015. This is
the third year that Veeva has been among the top ten vendors, and has
been steadily increasing its standing among life sciences executives
over the past three years – jumping to 3rd most preferred
provider from 8th two years ago.
Veeva delivers industry cloud software solutions to help life sciences
companies achieve their most pressing strategic objectives – bringing
drugs to market faster and more efficiently, maximizing revenues, and
maintaining compliance with government regulations. Veeva was the only
industry cloud vendor to top the list.
In addition to its most preferred status, Veeva
has been named a ‘Leader’ in the IDC Marketscape Worldwide Life
Science CRM Software 2015 Vendor Assessment, and ranked the 3rd
life sciences software vendor globally by IDC Health Insights’ Vendor
Assessment: 2014 Top 10 Life Science Software Vendors report.ii
Veeva climbed two positions this year from last year’s rankings.
IDC cites Veeva’s leading-edge functionality and ease of use as among
the best in the industry. The survey noted Veeva’s industry expertise as
a key differentiator. “The company's sole focus on the life science
industry boosts its unique understanding of market wants and needs. This
was echoed by the firm's customers, which gave Veeva's life science
market expertise extremely high marks,” the report notes.iii
“We are honored by this recognition, especially since it comes from our
most important stakeholder, our customers,” said Paul Shawah, vice
president of product marketing for Veeva. “Our ranking as one of the top
providers to the industry reflects our commitment to continually
innovating and expanding our industry cloud solutions to deliver
extraordinary value to life sciences companies as we partner with them
to achieve their strategic objectives.”
In addition to the recognition from IDC, Veeva also recently received
two other notable awards. Nucleus
Research named Veeva ‘Leader’ in its Technology Value Matrix for CRM
for the third year in a row. Nucleus Research considers candidates’
track record of innovation in system functionality and usability,
particularly in the areas of sales, marketing, and customer service.
The only life sciences-specific provider named a leader by Nucleus,
“Veeva offers an accelerated time to value with its industry-specific
products because solutions built for a particular industry are able to
provide more out-of-the-box capabilities, which decreases implementation
time and cost,” the report states.
Veeva Commercial Cloud was also singled out by PharmaVOICE as ‘Most
Innovative Platform’ for 2014, as judged against hundreds of nominations
from across the life sciences industry. Veeva Commercial Cloud brings
together the data, content, and interactions needed for life sciences
companies to deliver a fully coordinated and compliant customer
experience across channels.
Additional Information:
• For more on Veeva Commercial Cloud, please visit: veeva.com/CommercialCloud
• Stay updated on the latest Veeva news on LinkedIn: www.linkedin.com/company/veeva-systems
• Follow @veevasystems on Twitter: www.twitter.com/veevasystems
• Like Veeva on Facebook: www.facebook.com/veevasystems
About IDC MarketScape
IDC MarketScape vendor analysis model is designed to provide an overview
of the competitive fitness of ICT (information and communications
technology) suppliers in a given market. The research methodology
utilizes a rigorous scoring methodology based on both qualitative and
quantitative criteria that results in a single graphical illustration of
each vendor’s position within a given market. IDC MarketScape provides a
clear framework in which the product and service offerings, capabilities
and strategies, and current and future market success factors of IT and
telecommunications vendors can be meaningfully compared. The framework
also provides technology buyers with a 360-degree assessment of the
strengths and weaknesses of current and prospective vendors.
About Veeva Systems
Veeva Systems Inc. is a leader in cloud-based software for the global
life sciences industry. Committed to innovation, product excellence, and
customer success, Veeva has more than 275 customers, ranging from the
world's largest pharmaceutical companies to emerging biotechs. Veeva is
headquartered in the San Francisco Bay Area, with offices in Europe,
Asia, and Latin America. For more information, visit www.veeva.com.
Forward-looking statements
This release contains forward-looking statements, including the market
demand for and acceptance of Veeva’s products and services, the results
from use of Veeva’s products and services, and general business
conditions, particularly in the life sciences industry. Any
forward-looking statements contained in this press release are based
upon Veeva’s historical performance and its current plans, estimates,
and expectations, and are not a representation that such plans,
estimates, or expectations will be achieved. These forward-looking
statements represent Veeva’s expectations as of the date of this press
announcement. Subsequent events may cause these expectations to change,
and Veeva disclaims any obligation to update the forward-looking
statements in the future. These forward-looking statements are subject
to known and unknown risks and uncertainties that may cause actual
results to differ materially. Additional risks and uncertainties that
could affect Veeva’s financial results are included under the captions,
“Risk Factors” and “Management’s Discussion and Analysis of Financial
Condition and Results of Operations” in the company’s filing on Form
10-K for the period ended January 31, 2015. This is available on the
company’s website at www.veeva.com
under the Investors section and on the SEC’s website at www.sec.gov.
Further information on potential risks that could affect actual results
will be included in other filings Veeva makes with the SEC from time to
time.
i Leading Indicators in Life Science IT Spending Survey,
IDC Health Insights #HI255788, 1Q15
ii Vendor
Assessment: 2014 Top 10 Life Science Software Vendors, IDC Health
Insights #HI254753, March 2015
iii IDC MarketScape:
Worldwide Life Science CRM Software 2015 Vendor Assessment, IDC
Health Insights #HI255821e, May 2015
View source version on businesswire.com: http://www.businesswire.com/news/home/20150602006646/en/
Source: Veeva Systems